BCDA
BioCardia Inc.

5,757
Loading...
Loading...
News
all
press releases
Why BioCardia (BCDA) Stock Is Up 95% Today
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family. read more...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
BioCardia Expands Treatment in Heart Failure Trial
An update from BioCardia (BCDA) is now available. BioCardia, Inc. has announced a significant development in its Phase 3 CardiAMP Heart Failure II...
TipRanks Financial Blog·1y ago
News Placeholder
BioCardia Full Year 2023 Earnings: Misses Expectations
BioCardia ( NASDAQ:BCDA ) Full Year 2023 Results Key Financial Results Revenue: US$477.0k (down 65% from FY 2022). Net...
Simply Wall St·1y ago
News Placeholder
Q4 2023 BioCardia Inc Earnings Call Transcript
Related Stocks: NAS:BCDA...
GuruFocus·1y ago
News Placeholder
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
SUNNYVALE, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- BioCardia , Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Globe Newswire·1y ago
News Placeholder
Aper u des b n fices : BioCardia
BioCardia (NASDAQ:BCDA) publiera mercredi 27 mars son dernier rapport de r sultats. D chiffrez le rapport avec l'aide de Benzinga. D finition de b n fices, r sultat net et BPA Les b n fices et le BPA...
Benzinga·2y ago
News Placeholder
Anteprima degli utili di BioCardia
BioCardia (NASDAQ:BCDA) render noti i prossimi risultati degli utili mercoled 27 marzo. Ecco la guida di Benzinga con tutte le informazioni pi importanti per la pubblicazione degli utili. Cosa...
Benzinga·2y ago
News Placeholder
Un avance de las ganancias de BioCardia
El mi rcoles, 27 de marzo, BioCardia (NASDAQ:BCDA) publicar su ltimo informe de ganancias. El avance de Benzinga para BioCardia est incluido en el siguiente informe. Qu son ganancias, ingresos...
Benzinga·2y ago
News Placeholder
BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024
SUNNYVALE, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- BioCardia , Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Globe Newswire·2y ago
News Placeholder
BioCardia and StemCardia partners for heart failure treatment candidate
BioCardia and StemCardia partners for heart failure treatment candidate...
SeekingAlpha.com: All News·2y ago

Latest BCDA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.